Abstract
Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease, and lupus nephritis (LN) is the most common and severe complication of systemic lupus erythematosus, and the diagnosis and treatment of LN is closely related to the prognosis of systemic lupus erythematosus. Recently, promising LN biomarkers have been discovered that will be expected to provide guidance for the diagnosis and treatment of lupus kidney. Key words: Lupus nephritis; Biological markers; Disease activity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
